I seek to understand client needs and goals, and work tirelessly to deliver options that achieve outcomes they deserve, while cultivating a relaxed, open and consultative relationship.
Tony leads the firm’s outsourced pharmaceutical services and life sciences practices, specializing in mergers and acquisitions (M&A). He has executed sell-side and buy-side M&A transactions for private equity clients, publicly traded companies and privately held and family-owned businesses.
Tony specializes in M&A for highly differentiated outsourced pharmaceutical service businesses and clinical laboratories, helping them to understand the converging and dynamic end markets, identify growth opportunities, and leverage technology to deliver cost-saving solutions. His deep experience in pharmaceutical outsourcing and laboratory markets provides unique insights to assist growing life sciences companies (diagnostics and research products) that supply laboratories, contract research organizations, and pharmaceutical/biotechnology companies with the innovative products and technologies required to remain cutting edge.
Prior to joining Lincoln, Tony was a Vice President in the healthcare investment banking practice of GCA Savvian Advisors. Previously, he was an Associate at Vector Securities International and an Analyst in the Healthcare Corporate Finance group of RBC Capital Markets (formerly Dain Rauscher Wessels).
Tony earned a Bachelor of Science from the Carlson School of Management at the University of Minnesota.
Lincoln International is pleased to announce the merger of Optovue with Luneau Technology
Lincoln International is pleased to announce that High Street Capital has sold Avomeen to Element, a portfolio company of Bridgepoint
Lincoln International is pleased to announce MedTest Holdings, a portfolio company of Enhanced Healthcare Partners, has been sold to HORIBA
Lincoln International advised investment funds managed by Morgan Stanley Capital Partners in the acquisition of USHealthConnect Inc.
Lincoln International advised Alva-Amco Pharmacal on its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International advised UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, on its sale to Chr. Hansen Holding A/S (CPSE:CHR)
Lincoln International advised Verogen Inc., a portfolio company of Telegraph Hill Partners, on the acquisition of GEDmatch Incorporated
Perspectives featuring Anthony Crisman
Awakening of the Healthcare Consumer
Since the beginning of the Information Age, there has been discussion around the importance, emergence, and empowerment of the health care consumer. This has been enabled and driven by rapid… Read More
Interim/Post-COVID-19 Sector Outlook: Services & Products for Homebound Patients
Click the home healthcare sectors below to view key takeaways on the effects of COVID-19. Medical and Personal Services Skilled Home Healthcare Near term: REASONABLY STABLE / POSITIVE Long term:… Read More
COVID-19 Pandemic Could Accelerate Recent U.S. Healthcare Growth Trends
One hundred years after the 1918 Spanish Flu, the world is facing another pandemic: COVID-19. Government and healthcare officials are working around the clock to flatten the curve and slow… Read More